Catherine L Wetzel

1PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 20, 2021
Loss of HER2-positivity following neoadjuvant targeted therapy for breast cancer is not associated with inferior oncologic outcomes.

Catherine L Wetzel, Thomas L Sutton, Stuart Gardiner

Pageof 1

Frequent Collaborators

1 joint publications

Thomas L Sutton

1 joint publications

Nathalie Johnson